Translational Development Acquisition Corp. (TDACU) Financial Ratios & Valuation Metrics Analysis - P/E, ROE, Debt Ratios & Profitability - Stocknear

Translational Development...

NASDAQ: TDACU · Real-Time Price · USD
10.36
0.00 (0.00%)
At close: Aug 20, 2025, 3:59 PM

Translational Development Acquisition Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022
PE Ratio
-570.9 -83.49 -573.72
PEG Ratio
6.60 -0.14 n/a
PS Ratio
0.00 n/a n/a
PB Ratio
0.24 -79.86 -1.83K
P/FCF Ratio
-47.61 -198.73K -279.59K
P/OCF Ratio
-47.61 -198.73K -279.59K
OCF/S Ratio
-0.00 n/a n/a
Debt / Equity Ratio
36.21K -0.68 -11.72
Quick Ratio
3.09 0.00 0.12
Current Ratio
3.09 0.00 0.12
Asset Turnover
6.09K n/a n/a
Interest Coverage
-0.00 n/a n/a
Return on Equity
n/a 0.96 3.20
Return on Assets
n/a -240.25 -0.16
Return on Invested Capital
n/a 3.03 -0.3
Dividend Yield
0.00 n/a n/a
Payout Ratio
-1.77 n/a n/a
Gross Profit Margin
0.70 n/a n/a
Net Profit Margin
-0.00 n/a n/a
Pretax Profit Margin
-0.00 n/a n/a
Operating Profit Margin
-0.00 n/a n/a
FCF Margin
n/a n/a n/a
EBITDA Margin
-0.00 n/a n/a